Angiotensin-converting enzyme (ACE) inhibitors, angiotensin II receptor blockers (ARBs), and angiotensin receptor-neprilysin inhibitors (ARNIs) are essential medications used to improve the efficiency of the heart and protect it from long term damage. These drugs belong to a group of treatments that target the hormonal systems responsible for regulating blood pressure and fluid balance. By relaxing the blood vessels and reducing the workload on the heart muscle, these medications help the heart pump more easily, decrease symptoms such as breathlessness, and significantly improve the long term health prospects for individuals with heart failure.
What We’ll Discuss in This Article
- The primary function of ACE inhibitors in widening blood vessels.
- How ARBs provide an alternative for patients who cannot tolerate ACE inhibitors.
- The advanced role of ARNI medications in combined heart protection.
- Common side effects and the importance of regular blood tests.
- Why these medications are foundational to UK heart failure care.
- What to expect during the initial period of starting these treatments.
How ACE inhibitors support the heart muscle
ACE inhibitors help the heart by blocking the production of a hormone called angiotensin II, which naturally causes blood vessels to narrow and the body to retain salt and water. When blood vessels are narrow, the heart has to work much harder to push blood through them. By preventing the production of this hormone, ACE inhibitors allow the blood vessels to relax and widen, which lowers blood pressure and makes it significantly easier for the heart to circulate blood around the body.
According to NHS guidance on heart failure treatment, these medications are typically offered to most people with heart failure due to their proven ability to strengthen the heart over time. This protective effect helps to prevent the heart from becoming enlarged or further weakened. While they are highly effective, a common side effect is a persistent dry cough, which occurs because the medication can cause a buildup of a substance called bradykinin in the lungs.
The role of ARBs as an alternative treatment
Angiotensin II receptor blockers (ARBs) work in a very similar way to ACE inhibitors but they target the hormone system at a slightly different stage. Instead of stopping the production of angiotensin II, they block the places (receptors) where the hormone would usually act on the blood vessels. This results in the same beneficial effect of widening the vessels and reducing the pressure that the heart must pump against to deliver oxygen to the body.
NICE guidance for chronic heart failure recommends ARBs specifically for patients who experience a persistent cough or other side effects while taking ACE inhibitors. Because ARBs do not affect bradykinin levels in the same way, they provide the same cardiac protection without the irritation in the airways. Both ACE inhibitors and ARBs are vital for managing fluid levels and ensuring that the kidneys are not put under unnecessary strain by the heart condition.
Understanding ARNI (sacubitril valsartan) therapy
An ARNI is a more recent and advanced type of heart failure medication that combines two different actions into one tablet to provide superior protection for the heart. It contains a standard ARB (valsartan) to relax blood vessels and a second medicine called sacubitril. Sacubitril works by increasing the levels of natural peptides in the body that help the heart by promoting salt and water excretion and further relaxing the arteries.
This dual action provides a more comprehensive approach to managing heart strain than using an ACE inhibitor or ARB alone. In the UK, specialists often switch patients to an ARNI if their symptoms continue despite being on a standard dose of an ACE inhibitor. The goal of this transition is to further reduce the risk of hospitalisation and to provide the heart with the best possible environment to recover its pumping strength.
Monitoring and safety during treatment
Because these medications affect the kidneys and the levels of salts in your blood, you will require regular monitoring while taking them. When you first start an ACE inhibitor, ARB, or ARNI, or when your doctor increases the dose, you will need blood tests every one to two weeks. These tests check your kidney function and your potassium levels to ensure that the medication is working safely within your body.
| Feature | ACE Inhibitors | ARBs | ARNI |
| Primary Action | Stops hormone production | Blocks hormone receptors | Blocks receptors and boosts peptides |
| Common Cough | Yes (common side effect) | No (rarely causes cough) | No (rarely causes cough) |
| Standard Use | First line treatment | Used if ACE is not tolerated | Used for symptomatic patients |
It is also important to monitor your blood pressure, as these medications are designed to lower it. If your blood pressure becomes too low, you may feel dizzy or lightheaded, especially when standing up quickly. Your medical team will use the results of your blood tests and blood pressure readings to slowly increase your dose to the most effective level, a process known as titration.
Important safety considerations for ARNIs
If you are being switched from an ACE inhibitor to an ARNI, there is a very strict safety rule regarding the transition period. You must wait exactly 36 hours after taking your last dose of an ACE inhibitor before you take your first dose of an ARNI. This “washout period” is essential to prevent a rare but serious side effect called angioedema, which involves swelling of the deeper layers of the skin, including the face and throat.
This transition is always managed closely by your cardiologist or specialist heart failure nurse. Once the 36 hour period has passed, the ARNI is usually started at a low dose and gradually increased. Patients who are already taking an ARB do not typically need this specific washout period, but the switch will still be supervised to ensure that blood pressure and kidney function remain stable throughout the change.
Conclusion
ACE inhibitors, ARBs, and ARNIs are fundamental treatments that work by relaxing the blood vessels and reducing the hormonal stress placed on the heart. By making it easier for the heart to pump, these medications help to manage symptoms, prevent the condition from worsening, and support the heart muscle’s long term health. While they require careful monitoring through regular blood tests, they remain the most effective tools available in the UK for improving the lives of those with heart failure.
If you experience severe, sudden, or worsening symptoms, call 999 immediately. u have recently started one of these medications.
FAQ Section
Why do I need blood tests so often at the start?
These medications can affect how your kidneys work and change your potassium levels, so regular tests ensure the dose is safe for your body.
Can I take these medications if I have low blood pressure?
Your doctor will check your blood pressure carefully and may still prescribe these drugs at a very low dose because of their protective effects on the heart muscle.
What should I do if I develop a dry cough on an ACE inhibitor?
You should speak to your GP or heart failure nurse, as they can usually switch you to an ARB which provides similar benefits without the cough.
Is an ARNI better than an ACE inhibitor?
For many patients, an ARNI provides stronger protection against hospitalisation, but it is usually only prescribed by specialists after other treatments have been tried.
Will I have to take these medicines for the rest of my life?
In most cases, these medications are continued long term to provide ongoing protection for the heart and to prevent symptoms from returning.
Can I take anti-inflammatory painkillers like ibuprofen with these?
You should generally avoid anti-inflammatory drugs as they can interfere with how these heart medications work and may damage your kidneys.
Does it matter what time of day I take my heart medication?
It is best to take your medication at the same time every day to keep a steady level in your blood, but your pharmacist can advise on the best schedule for you.
Authority Snapshot
This article was created to provide the general public with clear, factual information regarding the role of blood pressure medications in heart failure care. It was authored by Dr. Rebecca Fernandez, a UK-trained physician with experience in cardiology and internal medicine. The content is strictly aligned with the clinical safety standards and treatment pathways established by the NHS and NICE.
